ProQR Therapeutics NV (PRQR)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Return on Assets (%) | -47.211 | -73.558 | -45.176 | -49.595 | -43.063 | -39.974 | -34.188 | -18.188 |
Return on Equity (%) | -54.714 | -94.39 | -55.896 | -60.563 | -61.93 | -72.591 | -73.018 | -52.804 |
Return on Invested Capital (%) | -51.509 | -78.206 | -49.434 | -54.903 | -47.9 | -54.559 | -68.014 | -69.236 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -4295.273 | -1478.028 | -408.505 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -4551.034 | -1612.856 | -431.67 |
Book Value Per Share | 2.163 | 1.079 | 2.148 | 1.738 | 1.045 | 1.512 | 0.773 | 0.491 |
Earnings Per Share | -1.595 | -1.198 | -0.855 | -1.046 | -0.86 | -0.823 | -0.773 | -0.334 |
Cash Per Share | 2.414 | 1.32 | 2.447 | 2.074 | 1.401 | 2.505 | 1.125 | 1.412 |
Working Capital Per Share | 2.255 | 1.155 | 2.322 | 1.921 | 1.288 | 2.189 | 1.583 | 1.03 |
Operating Profit Per Share | 0.075 | 0.041 | 0.134 | 0.036 | 0.175 | 0.032 | 0.057 | 0.078 |
EBIT Per Share | -1.595 | -1.199 | -0.859 | -1.049 | -0.859 | -0.822 | -0.769 | -0.33 |
EBITDA Per Share | -1.595 | -1.199 | -0.859 | -1.049 | -0.859 | -0.822 | -0.769 | -0.33 |
Free Cash Flow Per Share | -1.541 | -1.224 | -0.87 | -1.074 | -0.887 | -0.848 | -0.794 | -0.347 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 24,52M | 36,43M | 43,15M | 53,98M | 54,13M | 74,87M | 84,25M | 84,25M |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Actions en circulation | 74,87M | 84,25M | 84,25M | 84,25M | 84,25M | 84,25M | 84,25M | 84,25M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -2478.243 | N/A | -1268.855 | -665.477 | N/A | -172.022 | -45.868 | -210.981 |
Net Profit Margin (%) | -2551.778 | N/A | -1363.817 | -663.32 | N/A | -172.09 | -42.696 | -210.981 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 215,59M |
Ratio cours/bénéfice | -7,61 |
Ratio prix/ventes | 32,43 |
Ratio prix/liquidités | 1,8 |
Ratio prix/valeur comptable | 5,17 |
Rendement de dividende | - |
Actions en circulation | 81,35M |
Volume moyen (1 semaine) | 203,15k |
Volume moyen (1 mois) | 566,97k |
Variation sur 52 semaines | 29,70% |
Plus haut sur 52 semaines | 4,62 |
Plus bas sur 52 semaines | 1,61 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales